Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Finalizes Post-Market Benefit-Risk Guidance

Dec 30 2016

• By Elizabeth Orr

Related Content

Assessing Patient Impact From Recalls Often A Judgment Call, US FDA Says

Jul 12 2016

Additional Topics

United States Post Market Regulation & Studies Recalls Regulation Compliance Medical Device

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window